Tower Research Capital LLC (Trc) Veracyte, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Veracyte, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,815 shares of VCYT stock, worth $77,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,815
Previous 8,693
79.12%
Holding current value
$77,954
Previous $188,000
67.55%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$335 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$333 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$216 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$211 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$182 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.07B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...